What is Equilume?
Equilume operates at the forefront of equine health innovation, utilizing proprietary blue and red light technology to optimize the physiological well-being of horses. The company's product suite, which includes sophisticated smart Stable Lights and specialized Light Masks, is engineered to simulate natural daylight cycles. This scientific approach is designed to enhance fertility, improve performance metrics, and facilitate restorative rest for high-value equine assets. By bridging the gap between biological research and practical stable management, Equilume has established a unique market position as a leader in animal-centric light therapy solutions.
How much funding has Equilume raised?
Equilume has raised a total of $684K across 1 funding round:
Angel/Seed
$684K
Angel/Seed (2014): $684K, investors not publicly disclosed
Key Investors in Equilume
Undisclosed Investor
An undisclosed investor participating in the funding round, providing essential capital to support early-stage development and market entry.
What's next for Equilume?
With this major enterprise-level funding, Equilume is poised to accelerate its research and development pipeline, focusing on the expansion of its light-based therapeutic applications. The company is expected to prioritize the scaling of its distribution networks to meet the growing demand for evidence-based equine wellness products. Future strategic initiatives will likely involve deepening its scientific research partnerships to validate new applications for its light technology, ensuring that the firm maintains its competitive advantage in the specialized veterinary technology sector. As the company transitions into its next phase of growth, the focus will remain on operational excellence and the continued integration of its technology into professional equestrian facilities worldwide.
See full Equilume company page
